Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
The purpose of this study is to better understand how well the investigational treatment works in reducing body weight, improving body composition and weight-related health measures, and evaluating its safety and tolerability. Researchers will also study whether the investigational medication may help delay progression to type 2 diabetes in participants with prediabetes.
You may be able to join if you:
-Are at least 18 years of age
-Have obesity with a body mass index (BMI) of 30 or greater
-Have had a stable body weight prior to screening
-Have a history of at least one unsuccessful dietary effort to reduce body weight
-Do not have type 2 diabetes
-Are willing and able to attend study visits and follow study procedures
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]